Incannex Healthcare stock tumbles after filing $100M offering - Investing.com
3 hours ago • Google News
Incannex Healthcare Ltd ADR (IXHL)
US$ 0.202-10.62%
Price Chart
Key Statistics
Market Cap
$ 152.72M
P/E Ratio
0.00
Revenue (TTM)
$ 98K
Volume
13.32M
52W High
$ 3.12
52W Low
$ 0.08
Dividend Yield
0.00%
Beta
2.47
Technicals
50-Day MA
0.3081
200-Day MA
1.1919
52 Week High
3.12
52 Week Low
0.08
About IXHL
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with.
Employees
9
Headquarters
Sydney, NSW
CEO
Mr. Joel Bradley Latham
Latest News
Pre-market Movers: LHAI, OCTO, IXHL, COUR, NXTC… - RTTNews
5 hours ago • Google News
Incannex Healthcare IXHL Soars 33.66% on Positive OSA Trial Data - AInvest
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg